Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
1 clinical trials · Condition
◉ Watch Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
| Record | Firm | Date |
|---|---|---|
| Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation (NCT02113891) | Assistance Publique - Hôpitaux de Paris | 2015-02-01 |
Track Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation automatically
Every clearance here is in the API, with alerts when new ones post.